UPRA | Ukrainian Psychedelic Research Association | психоделічно асистована терапія | ПАТ | Ukraine - UKRAINIAN PSYCHEDELIC RESEARCH ASSOCIATION

23 million Ukrainians

are at a high risk of mental disorders due to shellings, forced relocation and the loss of loved ones.

3.5 million

are likely to be diagnosed with PTSD, a mental health disorder that some people develop after experiencing or witnessing a life-threatening event. Symptoms may include flashbacks, nightmares, severe anxiety and uncontrollable thoughts about the event.

Only

50%

of these patients are expected to recover completely after conventional therapy courses.

How can we help
the remaining 50%?

The answer is psychedelic-assisted therapy

Psychedelic-Assisted Therapy is a method of combining the effects of psychotherapy and psychedelic compounds. Such a method is proven to have a significant therapeutic superiority compared to existing treatments of PTSD and depression.

Breakthrough therapy designation

2017

MDMA

US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for MDMA for the treatment of PTSD.

2019

Psilocybin

US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for psilocybin for the treatment of Major Depressive Disorder.

He lost a friend in the war. He lost his fingers, foot, spleen and sense of life. The PTSD diagnosis, antidepressants — panic attacks have not disappeared. His reason for living was lost. But psychedelic therapy worked.

"My life has changed in one session."

Stanislav Gibadulin,
call sign Hitman.

Served in the Armed Forces from the beginning of the war in Donbas.

Read Hitman's story

UPRA is a non-profit organization advancing the clinical use of psychedelics in PTSD patients who have exhausted conventional therapeutic options. Together with partners, we work to change the legal framework, promote expanded access programs, educate health practitioners and support patients and their caregivers.